BX Swiss TOP 30 CHF
1.384,70
PKT
+20,72
PKT
+1,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.05.12 | Holcim hold | Vontobel Research | |
| 14.05.12 | Holcim neutral | Sarasin Research | |
| 14.05.12 | Julius Bär hold | Vontobel Research | |
| 14.05.12 | Adecco SA buy | Sarasin Research | |
| 14.05.12 | Zurich Insurance buy | Vontobel Research | |
| 11.05.12 | Zurich Insurance buy | ING | |
| 11.05.12 | Zurich Insurance buy | Vontobel Research | |
| 11.05.12 | UBS buy | Vontobel Research | |
| 11.05.12 | UBS hold | Vontobel Research | |
| 11.05.12 | Adecco SA buy | Vontobel Research | |
| 10.05.12 | Zurich Insurance neutral | Sarasin Research | |
| 10.05.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 10.05.12 | Holcim hold | Vontobel Research | |
| 10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 10.05.12 | Straumann hold | Vontobel Research | |
| 10.05.12 | Zurich Insurance buy | Vontobel Research | |
| 10.05.12 | Holcim neutral | Sarasin Research | |
| 09.05.12 | Adecco SA buy | ING | |
| 09.05.12 | Holcim hold | Vontobel Research | |
| 09.05.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 08.05.12 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 08.05.12 | Nestlé overweight | Morgan Stanley | |
| 08.05.12 | Swiss Life buy | Sarasin Research | |
| 08.05.12 | Adecco SA buy | Sarasin Research | |
| 08.05.12 | Lonza kaufen | Die Actien-Börse | |
| 08.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 08.05.12 | Swiss Life buy | Vontobel Research | |
| 08.05.12 | Adecco SA buy | Vontobel Research | |
| 07.05.12 | Swiss Re underperform | RBC Capital Markets | |
| 07.05.12 | Swiss Re kaufen | Hamburger Sparkasse AG (Haspa) | |
| 07.05.12 | Lonza hold | Vontobel Research | |
| 07.05.12 | Swiss Re buy | Vontobel Research | |
| 07.05.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 07.05.12 | Roche buy | Vontobel Research | |
| 04.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
| 04.05.12 | UBS buy | Nomura | |
| 04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
| 04.05.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 04.05.12 | Novartis buy | UBS AG | |
| 04.05.12 | Swiss Re buy | Sarasin Research |